Background: There are potential conflicts between authorities and companies to fund new
premium priced drugs especially where there are effectiveness, safety and/or budget …

Venous thromboembolism (VTE) is associated with high recurrence, mortality, and cost
burden. Direct oral anticoagulants (DOACs) are currently used for VTE treatment, and they …

Background: There are potential conflicts between authorities and companies to fund new
premium priced drugs especially where there are safety and/or budget concerns …

Aims The aim of the present study was to assess the effect of policy interventions–ie
reimbursement decisions, guidelines and regional recommendations–on the prescribing of …

Introduction: There has been a considerable increase in the use of proton pump inhibitors
(PPIs) in recent years due to their effectiveness versus H2 antagonists. This includes …

Objectives: Pharmaceutical expenditure has risen rapidly resulting in multiple reforms
across countries. This includes Korea. Review policies and initiatives undertaken in Europe …

Methods: The INR data were retrospectively obtained from all patients taking warfarin during
2014-2016 at a secondary healthcare system in rural Chhattisgarh, India. Patients attending …

Objectives: To provide early data regarding clinical utility of dabigatran in Al-Ain, United
Arab Emirates (UAE). Methods: This was an ethics approved retrospective cross sectional …

Aim: The formulary inclusion of direct oral anticoagulant (DOACs) in the government hospital
health services in Qatar is not comparative or restricted. Requests to include a DOAC in the …

Author’s Proof Author’s Queries Form Page 1 Author’s Proof Please check your proof carefully
and mark all corrections in the appropriate place. Annotate your corrections on-screen using …